Kardiorenal'nyyi neyrogormonal'nyy kontinuumu bol'nykh arterial'noygipertenziey, ego znacheniev klinicheskoy praktike


Cite item

Full Text

Abstract

References

  1. Brunner H, Cockcroft JR, Deanfield J et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23 (2): 233-46.
  2. Redon J, Williams B. Microalbuminuria in essential hypertension: redefining the threshold. J Hipertens 2002; 20 (3): 353-5.
  3. de Jong PE, de Zeeuw D. Renoprotective therapy: is it blood pressure or albuminuria that matters? Lancet 2005; 365: 913-4.
  4. Bоhm M, Reil JC, Danchin N et al. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens 2008; 26 (1): 18-25.
  5. Chobanian AV, Bakris GL, Black Hr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evalution, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560-72.
  6. Knaght EL, Kramer HM, CurhanGC. High-normal blood pressure and microalbuminuria. Am J Kidney Dis 2003; 41 (3): 588-95.
  7. Cottone S, Mule G, Nardi E et al. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21 (2): 167-72.
  8. Cirilo M, Senigalliesi L, Laurenzi M et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 1998; 158 (17): 1933-9.
  9. Nahas AM, Bello AK. Chonic kidney disease: the global challenge. Lancet 2005; 365: 301-40.
  10. Ruilope L, Segura J. Renal protection in diabetic patient benefits of first-line combination of perindopril-indapamide (Preterax). J Hypertens 2006; 24 (Suppl. 3): s9-s12.
  11. Bibbons-Domingo K, Chertow GM, Fried LF et al. Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study. Arch Intern Med 2006; 166 (13): 1396-402.
  12. Phillips RA, Diamond JA. Left ventricular hypertrophy, congestive heart failure, and coronary flow reserve abnormalities in hypertension. In Oparil S, Weber MA (eds): Hypertension: a companion to Brenner & Rector's The Kidney, Edition Philadelphia, Pennsylvania, US: WB Saunders Company 2000; 244-77.
  13. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology; 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 1105-87.
  14. Ахадов Ш.В., Рузбанова Г.Р., Молчанова Г.С. и др. Роль и целевой уровень отдельных компонентов ренин-ангиотензин-альдостероновой системы в развитии сердечно-сосудистых осложнений у больных артериальной гипертензией. Рос. кардиол. журн., 2009; 3 (77): 26-31.
  15. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in men. Anatomic validation of the method. Circulation 1977; 55 (4): 613-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 83918 от 12.09.2022 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 83917 от 12.09.2022 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies